Pathophysiology, Clinical Impact, and Evidence-Based Management of Type 2 Diabetes Mellitus with GLP-1 Receptor Agonists: A Narrative Review
Background: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder associated with substantial cardiovascular and renal complications. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as important therapeutic agents because of their glucose-lowering effects, weight reduction, and potential ca...